Biomarkers UK

Biomarkers UK 2022

Biognosys will be attending Biomarkers UK on May 3-4 in London, UK. You can find us at booth #38. Do not miss the oral presentation on May 3 at 12:30 pm (GMT+1) by our Director of Scientific Alliances, Yuehan Feng.

Oral presentation

An Integrated MS Proteomics Platform from Biomarker Discovery to Customized Assay Panelsheld

  • State-of-the-art mass spectrometry platform for unbiased biomarker discovery and development of customized assay panels across various biological specimen
  • Sub-protein resolution allows quantification of proteoforms such as post-translational modifications, isoforms, and mutations
  • Discovery of biomarker signatures through quantitative profiling of paired CSF-plasma samples from an Alzheimer’s Disease cohort

 

Yuehan Feng, Ph.D.
Director of Scientific Alliances
(Biognosys)

External oral presentation

Using A Dual Proteomics And Multiplexed IF Approach For The Detection Of Biomarkers Predictive For Response To ICI-Therapy

  • Identification of over 70 proteins differentially regulated in melanoma patients responding to therapy
  • Several immune phenotypes, including T cell subsets and M1 TAMs, significantly increased in responders

 

Anna Juncker-Jensen
Principal Scientist
(NeoGenomics)

Conference Page

Contact

    By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More